Candel Therapeutics, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Candel Therapeutics, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $125.0 thousand for the year ending 2022.

  • Candel Therapeutics, Inc. showed an increase of +0.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2021 to 2022.
  • This data is from Candel Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 28, 2024.
  • XBRL data for this metric is available from 2020 to 2022 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2020 to 2022), Candel Therapeutics, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 0.0%.
  • Historical annual values: Fiscal year 2022: $125.0 thousand | Fiscal year 2021: $125.0 thousand | Fiscal year 2020: $125.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: